Unsurprisingly, PLK1 is expressed in various types of malignancy and, despite some of them being described as a tumor suppressor (reviewed in [155,156]), its overexpression was widely correlated to poor prognosis in cancer, including BC [30,107,150,157,158,159,160,161,162,163,164]. Here, PLK1 is linked to cancer.